Fundraising Fox
/Companies
Sign in

NV Medtech

Reno, US · Founded 2021 · Delaware corporation

Find your way into NV Medtech

Sign up to see every warm intro you have to NV Medtech

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NV Medtech team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

NVMedtech develops the TUBE flow diverter, a minimally invasive implant that treats brain aneurysms by promoting rapid aneurysm occlusion and tissue growth across the aneurysm neck. The device is a medical implant for neurovascular intervention, offering high surface coverage, high pore density, and a heparin surface coating.

HealthtechMedical Devices

Founders & leadership

GB
George B. WallaceChief Executive OfficerExecutive Officer, Director at Encompass Technologies
JE
Jeffrey EstesExecutive

Board

CP
Christopher P. MartinBoard director
WK
William KellyBoard director

Reported raises · per SEC filings

Form D private placements

$20.9M disclosed across 1 round · 2026

▶$20.9MraisedJun 2026 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher P. MartinDirector
  • William KellyDirector
  • George B. WallaceExecutive Officer, Director
  • Jeffrey EstesExecutive Officer
Offering amount
$20.9M
Amount sold
$20.9M
First sale
May 2026
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does NV Medtech do?
NVMedtech develops the TUBE flow diverter, a minimally invasive implant that treats brain aneurysms by promoting rapid aneurysm occlusion and tissue growth across the aneurysm neck. The device is a medical implant for neurovascular intervention, offering high surface coverage, high pore density, and a heparin surface coating.
How much funding has NV Medtech raised?
NV Medtech has disclosed $20.9M raised across 1 round.
Where is NV Medtech headquartered?
NV Medtech is headquartered in Reno, US.